Recombinant influenza vaccine (H3 antigens, with or without adjuvant)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Recombinant influenza vaccine (H3 antigens, with or without adjuvant), covering 2025-09-17 to 2025-09-17. Get the full timeline:
Most recent: Clinical Trial Update: Study of Recombinant Influenza Vaccine Containing Different H3 Antigens Without or With Adjuvant in Healthy Adult Subjects [Phase 1]